This funding opportunity supports research projects that integrate imaging and fluid-based tumor monitoring assays during cancer therapy in patients. The goal is to determine the optimal use of these modalities for characterizing therapy response and detecting emergence of resistance, enhancing cancer treatment strategies.
Eligible applicants include a wide range of U.S.-based organizations such as nonprofits, institutions of higher education, government entities, small businesses, and tribal organizations. Non-domestic entities and non-domestic components of U.S. organizations are not eligible.
